| Date Filed | Type | Description |
| 10/02/2023 |
4
| Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 5,797 shares
@ $0 |
|
| 10/02/2023 |
4
| HUNT RONALD (10% Owner) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 3,035 shares
@ $0 |
|
| 10/02/2023 |
4
| Chin Mark (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 3,035 shares
@ $0 |
|
| 07/06/2023 |
4
| Chin Mark (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 18,656 shares
@ $0 |
|
| 07/06/2023 |
4
| HUNT RONALD (10% Owner) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 18,656 shares
@ $0 |
|
| 07/06/2023 |
4
| Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 35,634 shares
@ $0 |
|
| 04/04/2023 |
4
| Viney Joanne L. (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 21,028 shares
@ $0 |
|
| 04/04/2023 |
4
| Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 34,925 shares
@ $0 |
|
| 04/04/2023 |
4
| HUNT RONALD (10% Owner) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 18,285 shares
@ $0 |
|
| 04/04/2023 |
4
| Colowick Alan (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 16,456 shares
@ $0 |
|
| 04/04/2023 |
4
| Chin Mark (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 18,285 shares
@ $0 |
|
| 03/27/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2023 |
4
| Lanza Frank J (Principal Fin. & Acctng Ofc.) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 65,000 options to buy
@ $0.89, valued at
$57.9k
|
|
| 01/26/2023 |
4
| Walker Luke Nathaniel (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.89, valued at
$89k
|
|
| 01/26/2023 |
4
| EASTLAND JULIA MARIE (President and CEO) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 407,600 options to buy
@ $0.89, valued at
$362.8k
|
|
| 11/29/2022 |
4
| Lanza Frank J (Principal Fin. & Acctng Ofc.) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 86,438 options to buy
@ $0.697, valued at
$60.2k
|
|
| 10/04/2022 |
4
| Walker Luke Nathaniel (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 305,000 options to buy
@ $1.08, valued at
$329.4k
|
|
| 10/04/2022 |
3
| Walker Luke Nathaniel (Chief Medical Officer) has filed a Form 3 on Harpoon Therapeutics, Inc. |
| 09/19/2022 |
3
| Lanza Frank J (Principal Fin. & Acctng Ofc.) has filed a Form 3 on Harpoon Therapeutics, Inc. |
| 09/19/2022 |
4
| SILVERNAIL LAUREN P (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 20,335 options to buy
@ $1.62, valued at
$32.9k
|
|
| 09/19/2022 |
3
| SILVERNAIL LAUREN P (Director) has filed a Form 3 on Harpoon Therapeutics, Inc. |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| BAILES JOSEPH S (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 10,167 options to buy
@ $2.01, valued at
$20.4k
Granted 31,428 options to buy
@ $2.01, valued at
$63.2k
|
|
| 02/01/2022 |
4
| Wesche Holger (Chief Scientific Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 135,000 options to buy
@ $5.03, valued at
$679.1k
|
|
| 02/01/2022 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 155,000 options to buy
@ $5.03, valued at
$779.7k
|
|
| 02/01/2022 |
4
| Erbez Georgia (CFO) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 115,000 options to buy
@ $5.03, valued at
$578.5k
|
|
| 11/15/2021 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 155,000 options to buy
@ $7.73, valued at
$1.2M
|
|
|